Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Smoking Increases the Risk of Hepatocellular Carcinoma and Cardiovascular Disease in Patients with Metabolic-Associated Fatty Liver Disease
Jeong‐Ju Yoo, Man Young Park, Eun Ju Cho, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3336-3336
Open Access | Times Cited: 16

Showing 16 citing articles:

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 281
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 54
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients
Maria Eva Argenziano, Mi Na Kim, Michele Montori, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 922-940
Closed Access | Times Cited: 8
Environmental exposures and the risk of hepatocellular carcinoma
Divya Rayapati, Katherine A. McGlynn, John D. Groopman, et al.
Hepatology Communications (2025) Vol. 9, Iss. 2
Closed Access
Prevalence of advanced hepatic fibrosis and individualization of associated risk factors by Bayesian analysis in MASLD patients in French cardio-metabolic health networks
M Doffoël, Frédéric Chaffraix, Archia Chahard, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316158-e0316158
Open Access
Cluster analysis of diet and lifestyle factors associated with metabolic dysfunction-associated steatotic liver disease: findings from Korean Genome and Epidemiology Study
Jong-Hee Lee, Ha Eun Ryu, Taehwa Han, et al.
Endocrine (2025)
Closed Access
Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
В. Т. Ивашкин, О. М. Драпкина, M. V. Maevskaya, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2025) Vol. 35, Iss. 1, pp. 94-152
Open Access
A comprehensive analysis of the impact of smoking on adverse clinical outcomes of steatotic liver diseases
Keungmo Yang, Jae Jun Lee, Ji Won Han, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Associations of life’s essential 8 with MAFLD and liver fibrosis among US adults: a nationwide cross-section study
Depeng Liang, Jie Zhang, Li Lu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 4
Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database
Pojsakorn Danpanichkul, Yanfang Pang, Thanida Auttapracha, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1133-1133
Open Access
Heavy Smoking Increases Early Mortality Risk in Patients with Hepatocellular Carcinoma after Curative Treatment
Jaejun Lee, Jong Young Choi, Soon Kyu Lee
Journal of Liver Cancer (2024) Vol. 24, Iss. 2, pp. 253-262
Open Access | Times Cited: 3
Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma
Natchaya Polpichai, Sakditad Saowapa, Pojsakorn Danpanichkul, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6770-6770
Open Access | Times Cited: 3
The Role of Dietary Ingredients and Herbs in the Prevention of Non-Communicable Chronic Liver Disease
Monika Maćków, Tomasz Dziubyna, Tatiana Jamer, et al.
Nutrients (2024) Vol. 16, Iss. 20, pp. 3505-3505
Open Access | Times Cited: 1
Impacts of smoking on alcoholic liver disease: a nationwide cohort study
Jeong‐Ju Yoo, Dong Hyeon Lee, Sang Gyune Kim, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Metabolic-associated steatotic liver disease and hepatocellular carcinoma
Giovanni Catalano, Odysseas P. Chatzipanagiotou, Jun Kawashima, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 17, pp. 2283-2291
Closed Access
Addressing the essentials of the recent guidelines for managing patients with metabolic dysfunction-associated steatotic liver disease
Dimitrios Karagiannakis, Katerina Stefanaki, Stavroula Α. Paschou, et al.
HORMONES (2024)
Closed Access
Association between the Life's essential 8 health behaviors score and all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease
Yan Han, Jing Tang, Na Wu, et al.
Metabolism (2024) Vol. 163, pp. 156096-156096
Closed Access
Page 1

Scroll to top